Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Nicotinic Acid in the Hemodialysis Patients With Hyperphosphatemia

NCT02836184 is registered in ClinicalTrials.gov with Jiujiang No.1 People's Hospital as lead sponsor.

NCT NCT02836184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02836184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Nicotinic Acid in the Hemodialysis Patients With Hyperphosphatemia
Lead sponsor
Jiujiang No.1 People's Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2016
Completion date
September 30, 2016
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperphosphatemia